首页8QQ • FRA
add
AbCellera Biologics Inc
昨日收盘价
€2.22
当日价格范围
€2.25 - €2.25
年度波幅
€1.70 - €3.91
市值
7.69亿 USD
平均交易量
275.00
市盈率
-
股息率
-
主要交易所
NASDAQ
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
收入 | 505.00万 | -44.98% |
经营支出 | -27.10万 | -101.02% |
净收入 | -3421.00万 | 27.44% |
净利润率 | -677.43 | -31.88% |
每股收益 | -0.12 | 25.00% |
息税折旧摊销前利润 | -2604.28万 | 55.50% |
有效税率 | 26.95% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 6.26亿 | -17.75% |
总资产 | 13.61亿 | -8.57% |
负债总额 | 3.04亿 | -9.32% |
权益总额 | 10.56亿 | — |
发行在外的股份 | 2.98亿 | — |
市净率 | 0.62 | — |
资产回报率 | -7.40% | — |
资本回报率 | -8.97% | — |
现金流
现金净变动
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
净收入 | -3421.00万 | 27.44% |
来自运营的现金 | -800.00万 | 59.21% |
投资现金 | 3570.30万 | 246.79% |
融资现金 | 414.20万 | 10.01% |
现金净变动 | 2968.50万 | 175.92% |
自由现金流 | -7243.99万 | -28,861.47% |
简介
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
成立时间
2012
员工数量
596
